The Latest in Lymphoma & Plasma Cell Disorders

Researchers question validity of NCCN guidelines

March 8, 2018

FDA approves label update for nivolumab

March 8, 2018

Study confirms higher risk of infection with CB transplant

March 1, 2018

Company withdraws application for idelalisib

March 1, 2018

CHMP endorses drug delivery system

March 1, 2018

Expanded UCB product can stand alone

February 27, 2018

AYA cancer patients lost to follow-up

February 20, 2018

Intervention helps kids stay active after cancer treatment

February 19, 2018

Study reveals lack of sexual aids for cancer survivors

February 18, 2018

Antibody has ‘very promising activity’ in rel/ref CTCL

February 15, 2018

ASCO, NCCN release guidelines on checkpoint inhibitors

February 15, 2018

Drug appears safe and active in PTCL, CTCL

February 13, 2018

FDG PET can’t replace BM biopsy, study suggests

February 12, 2018

Inhibitor provides clinical improvement in MF

February 12, 2018

Drug may be option for B- and T-cell lymphomas

February 9, 2018